ANI Pharmaceuticals Inc (ANIP)
55.86
+0.76
(+1.38%)
USD |
NASDAQ |
Nov 21, 16:00
55.82
-0.04
(-0.07%)
After-Hours: 20:00
ANI Pharmaceuticals Max Drawdown (5Y): 72.96% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2024 | 72.96% |
| September 30, 2024 | 72.96% |
| August 31, 2024 | 72.96% |
| July 31, 2024 | 72.96% |
| June 30, 2024 | 72.96% |
| May 31, 2024 | 72.96% |
| April 30, 2024 | 72.96% |
| March 31, 2024 | 72.96% |
| February 29, 2024 | 72.96% |
| January 31, 2024 | 72.96% |
| December 31, 2023 | 72.96% |
| November 30, 2023 | 72.96% |
| October 31, 2023 | 72.96% |
| September 30, 2023 | 72.96% |
| August 31, 2023 | 72.96% |
| July 31, 2023 | 72.96% |
| June 30, 2023 | 72.96% |
| May 31, 2023 | 72.96% |
| April 30, 2023 | 72.96% |
| March 31, 2023 | 72.96% |
| February 28, 2023 | 72.96% |
| January 31, 2023 | 72.96% |
| December 31, 2022 | 72.96% |
| November 30, 2022 | 72.96% |
| October 31, 2022 | 72.96% |
| Date | Value |
|---|---|
| September 30, 2022 | 72.96% |
| August 31, 2022 | 72.96% |
| July 31, 2022 | 72.96% |
| June 30, 2022 | 72.96% |
| May 31, 2022 | 72.26% |
| April 30, 2022 | 72.26% |
| March 31, 2022 | 72.26% |
| February 28, 2022 | 72.26% |
| January 31, 2022 | 72.26% |
| December 31, 2021 | 72.26% |
| November 30, 2021 | 72.26% |
| October 31, 2021 | 72.26% |
| September 30, 2021 | 72.26% |
| August 31, 2021 | 72.26% |
| July 31, 2021 | 72.26% |
| June 30, 2021 | 72.26% |
| May 31, 2021 | 72.26% |
| April 30, 2021 | 72.26% |
| March 31, 2021 | 73.52% |
| February 28, 2021 | 77.06% |
| January 31, 2021 | 79.52% |
| December 31, 2020 | 79.52% |
| November 30, 2020 | 79.52% |
| October 31, 2020 | 79.52% |
| September 30, 2020 | 79.52% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
72.26%
Minimum
Apr 2021
79.52%
Maximum
Nov 2019
74.51%
Average
72.96%
Median
Jun 2022
Max Drawdown (5Y) Benchmarks
| Windtree Therapeutics Inc | 99.99% |
| Allogene Therapeutics Inc | -- |
| AIM ImmunoTech Inc | 99.76% |
| Protalix BioTherapeutics Inc | 94.38% |
| Armata Pharmaceuticals Inc | 99.88% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -17.51 |
| Beta (5Y) | 0.7063 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 45.70% |
| Historical Sharpe Ratio (5Y) | -0.1836 |
| Historical Sortino (5Y) | -0.2832 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 21.33% |